208 related articles for article (PubMed ID: 12161739)
1. Adenotonsillar enlargement in pediatric organ transplant recipients: a cross-sectional analysis.
Chiang S; Vu MC; Nguyen M; Strocker A; Horvath S; Shapiro N
Otolaryngol Head Neck Surg; 2002 Jul; 127(1):109-14. PubMed ID: 12161739
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for adenotonsillar hypertrophy in children following solid organ transplantation.
Shapiro NL; Strocker AM; Bhattacharyya N
Int J Pediatr Otorhinolaryngol; 2003 Feb; 67(2):151-5. PubMed ID: 12623151
[TBL] [Abstract][Full Text] [Related]
3. Adenotonsillar hypertrophy and Epstein-Barr virus in pediatric organ transplant recipients.
Shapiro NL; Strocker AM
Laryngoscope; 2001 Jun; 111(6):997-1001. PubMed ID: 11404611
[TBL] [Abstract][Full Text] [Related]
4. The validity of the OSA-18 among three groups of pediatric patients.
Strocker AM; Carrer A; Shapiro NL
Int J Pediatr Otorhinolaryngol; 2005 Feb; 69(2):241-7. PubMed ID: 15656959
[TBL] [Abstract][Full Text] [Related]
5. Adenotonsillar enlargement in pediatric patients following solid organ transplantation.
Huang RY; Shapiro NL
Arch Otolaryngol Head Neck Surg; 2000 Feb; 126(2):159-64. PubMed ID: 10680866
[TBL] [Abstract][Full Text] [Related]
6. Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus.
Sokal EM; Antunes H; Beguin C; Bodeus M; Wallemacq P; de Ville de Goyet J; Reding R; Janssen M; Buts JP; Otte JB
Transplantation; 1997 Nov; 64(10):1438-42. PubMed ID: 9392308
[TBL] [Abstract][Full Text] [Related]
7. Risk factors and clinical outcomes of pediatric liver transplant recipients with post-transplant lymphoproliferative disease in a multi-ethnic Asian cohort.
Huang JG; Tan MYQ; Quak SH; Aw MM
Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29071779
[TBL] [Abstract][Full Text] [Related]
8. A review of adenotonsillar hypertrophy and adenotonsillectomy in children after solid organ transplantation.
Roberts J; Powell J; Mather MW; Powell S; Brodlie M
Int J Pediatr Otorhinolaryngol; 2018 Nov; 114():29-35. PubMed ID: 30262363
[TBL] [Abstract][Full Text] [Related]
9. Adenotonsillar histopathology after organ transplantation.
Williamson RA; Huang RY; Shapiro NL
Otolaryngol Head Neck Surg; 2001 Sep; 125(3):231-40. PubMed ID: 11555759
[TBL] [Abstract][Full Text] [Related]
10. Association between Epstein-Barr virus seroconversion and immunohistochemical changes in tonsils of pediatric solid organ transplant recipients.
Shapiro NL; Tang CG; Bhattacharyya N
Laryngoscope; 2011 Aug; 121(8):1718-25. PubMed ID: 21792960
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis and Epstein-Barr virus in the tonsils of transplant recipients and healthy controls.
Mowry SE; Strocker AM; Chan J; Takehana C; Kalantar N; Bhuta S; Shapiro NL
Arch Otolaryngol Head Neck Surg; 2008 Sep; 134(9):936-9. PubMed ID: 18794437
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for posttransplant lymphoproliferative disorder in pediatric liver transplant recipients with cytomegalovirus antigenemia.
Kim JM; Lee SK; Kim SJ; Joh JW; Kwon CH; Choe YH; Shin M; Kim EY; Moon JI; Jung GO; Choi GS
Transplant Proc; 2010 Apr; 42(3):895-9. PubMed ID: 20430199
[TBL] [Abstract][Full Text] [Related]
13. Post-transplantation lymphoproliferative disorders localizing in the adenotonsillar region: report from the PTLD.Int survey.
Khedmat H; Taheri S
Ann Transplant; 2011; 16(1):109-16. PubMed ID: 21436784
[TBL] [Abstract][Full Text] [Related]
14. Adenotonsillar pathology in post-transplant patients.
Roy S; Vivero RJ; Smith LP
Int J Pediatr Otorhinolaryngol; 2008 Jun; 72(6):865-8. PubMed ID: 18395271
[TBL] [Abstract][Full Text] [Related]
15. Impact of Epstein-Barr virus donor and recipient serostatus on the incidence of post-transplant lymphoproliferative disorder in kidney transplant recipients.
Sampaio MS; Cho YW; Shah T; Bunnapradist S; Hutchinson IV
Nephrol Dial Transplant; 2012 Jul; 27(7):2971-9. PubMed ID: 22273720
[TBL] [Abstract][Full Text] [Related]
16. Posttransplant lymphoproliferative disorder after liver and kidney transplant.
Akar Özkan E; Özdemir BH; Deniz EE; Tunca MZ; Haberal M
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():142-8. PubMed ID: 24635813
[TBL] [Abstract][Full Text] [Related]
17. Adolescents are more likely to develop posttransplant lymphoproliferative disorder after primary Epstein-Barr virus infection than younger renal transplant recipients.
Smith JM; Corey L; Healey PJ; Davis CL; McDonald RA
Transplantation; 2007 Jun; 83(11):1423-8. PubMed ID: 17565314
[TBL] [Abstract][Full Text] [Related]
18. Association of immunosuppressive maintenance regimens with posttransplant lymphoproliferative disorder in kidney transplant recipients.
Sampaio MS; Cho YW; Shah T; Bunnapradist S; Hutchinson IV
Transplantation; 2012 Jan; 93(1):73-81. PubMed ID: 22129761
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr DNA serology and positron-emission tomography imaging of the head and neck in pediatric transplant recipients.
Sidell D; Venick RS; Shapiro NL
Laryngoscope; 2014 May; 124(5):1236-41. PubMed ID: 24105893
[TBL] [Abstract][Full Text] [Related]
20. Identifying predictive factors for posttransplant lymphoproliferative disease in pediatric solid organ transplant recipients with Epstein-Barr virus viremia.
Weintraub L; Weiner C; Miloh T; Tomaino J; Joashi U; Benchimol C; Strauchen J; Roth M; Wistinghausen B
J Pediatr Hematol Oncol; 2014 Nov; 36(8):e481-6. PubMed ID: 24878618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]